Turn Therapeutics Inc. (NasdaqGM: TTRX)
Health Care · Pharmaceuticals · US
$12.00
-9.98% today · +84.3% 1Y
Turn Therapeutics Inc. (NasdaqGM: TTRX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $357.46M and employs 2 people.
Over the last twelve months the share price has gained 84.3%, trading between 2.57 and 16.45.
Tweenvest scores Turn Therapeutics Inc. across four factors: quality 41/100, value 46/100. Its strongest factor is value.
TTRX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $357.46M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.29
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $16.45
- 52-week low
- $2.57
- Avg volume (3M)
- —
- Shares outstanding
- 29.79M
- Employees
- 2
- Next earnings
- —
About Turn Therapeutics Inc.
Turn Therapeutics Inc., officially known as Global Health Solutions, Inc., is a pharmaceutical enterprise dedicated to developing treatments for conditions affecting the skin, nails, and eyes. The company utilizes a proprietary drug delivery system engineered to effectively permeate skin and nail tissues. This advanced technology is integrated into their solutions for both acute and chronic wound care, specifically designed to help combat antibiotic resistance. Consequently, these products empower healthcare institutions to effectively manage a broad spectrum of dermatological challenges, encompassing everything from sudden injuries and persistent wounds to general skin ailments and specific dermatoses. Global Health Solutions, Inc. was established in 2015 and maintains its headquarters in Westlake Village, California.
- ISIN
- US90021W1053
- Founded
- 2015
- Listed since
- Oct 8, 2025
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Zhejiang Xinguang Pharmaceutical Co., Ltd.SZSE: 300519 | $362.13M | CN¥15.16 | +2.29% |
| Relmada Therapeutics, Inc.NasdaqCM: RLMD | $361.61M | $3.39 | -5.83% |
| ASKA Pharmaceutical Holdings Co.,Ltd.TSE: 4886 | $359.39M | ¥2,004.00 | -1.28% |
| Suzhou Fushilai Pharmaceutical Co., Ltd.SZSE: 301258 | $357.63M | CN¥27.04 | -1.31% |
| ShanXi C&Y Pharmaceutical Group Co.,LTD.SZSE: 300254 | $356.35M | CN¥9.28 | +0.98% |
| Qinghai Spring Medicinal Resources Technology Co., Ltd.SHSE: 600381 | $352.91M | CN¥4.13 | -1.67% |
| Canopy Growth CorporationTSX: WEED | $349.86M | CA$1.18 | -2.48% |
| Jilin Jian Yisheng Pharmaceutical Co., Ltd.SZSE: 002566 | $349.82M | CN¥7.08 | +0.28% |
Figures last refreshed Oct 11, 2026.